These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 6382503)

  • 1. Tumor cell hybridization and neoplastic progression.
    Hart IR
    Symp Fundam Cancer Res; 1983; 36():133-43. PubMed ID: 6382503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple human chromosomes carrying tumor-suppressor functions for the mouse melanoma cell line B16-F10, identified by microcell-mediated chromosome transfer.
    Kugoh H; Nakamoto H; Inoue J; Funaki K; Barrett JC; Oshimura M
    Mol Carcinog; 2002 Nov; 35(3):148-56. PubMed ID: 12410566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
    J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of generation of major karyotypic abnormalities in relationship to the metastatic potential of B16 murine melanoma.
    Kendal WS; Wang RY; Hsu TC; Frost P
    Cancer Res; 1987 Jul; 47(14):3835-41. PubMed ID: 3594440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype.
    Barsky SH; Sternlicht MD; Safarians S; Nguyen M; Chin K; Stewart SD; Hiti AL; Gray JW
    Oncogene; 1997 Oct; 15(17):2077-91. PubMed ID: 9366525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system.
    Stackpole CW; Alterman AL; Fornabaio DM
    Invasion Metastasis; 1985; 5(3):125-43. PubMed ID: 3888909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
    Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
    J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties.
    Nicolson GL; Dulski K; Basson C; Welch DR
    Invasion Metastasis; 1985; 5(3):144-58. PubMed ID: 3997411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of spontaneous in vivo tumor-host cell fusion to tumor progression and metastasis evaluated using a series of lectin-resistant mutant tumor sublines.
    Kerbel RS; Lagarde AE; Dennis JW; Nestel FP; Donaghue TP; Siminovitch L; Fulchignoni-Lataud MC
    Symp Fundam Cancer Res; 1983; 36():47-79. PubMed ID: 6382520
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of organ selectivity in the determination of metastatic patterns of B16 melanoma.
    Hart IR; Fidler IJ
    Cancer Res; 1980 Jul; 40(7):2281-7. PubMed ID: 7388794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell.
    Fidler IJ; Talmadge JE
    Cancer Res; 1986 Oct; 46(10):5167-71. PubMed ID: 3756870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of protein phosphorylation in metastatic variants of B16 melanoma.
    Greig RG; Caltabiano L; Reid R; Feild J; Poste G
    Cancer Res; 1983 Dec; 43(12 Pt 1):6057-65. PubMed ID: 6640547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6.
    Miele ME; Robertson G; Lee JH; Coleman A; McGary CT; Fisher PB; Lugo TG; Welch DR
    Mol Carcinog; 1996 Apr; 15(4):284-99. PubMed ID: 8634087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties.
    Irimura T; Gonzalez R; Nicolson GL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3411-8. PubMed ID: 7260906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells.
    MacDougall JR; Bani MR; Lin Y; Rak J; Kerbel RS
    Cancer Res; 1995 Sep; 55(18):4174-81. PubMed ID: 7664294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.